img

Global and United States Autologous Cell Therapy Products Market Report & Forecast 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and United States Autologous Cell Therapy Products Market Report & Forecast 2024-2034

Autologous cell therapy is a medical treatment approach that involves using a patient's own cells to treat a specific medical condition or promote healing. This type of therapy is personalized and based on the principle that cells from the patient's own body are less likely to trigger immune responses or rejection, making it a potentially effective and safe treatment option for various conditions.
Market Analysis and InsightsGlobal and United States Autologous Cell Therapy Products Market
This report focuses on global and United States Autologous Cell Therapy Products market, also covers the segmentation data of other regions in regional level and county level.
The global Autologous Cell Therapy Products revenue was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during the forecast period (2024-2034).
In United States the Autologous Cell Therapy Products revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2024-2034).
The global key players of Autologous Cell Therapy Products include Novartis, Gilead Sciences, Bristol-Myers Squibb, Johnson & Johnson, Autolus Therapeutics, FOSUNKite, JW Therapeutics, CARsgen Therapeutics and Sorrento Therapeutics, etc. The global five biggest players hold a share of % in 2022.
Global Autologous Cell Therapy Products Scope and Market Size
Autologous Cell Therapy Products market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Autologous Cell Therapy Products market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.
For United States market, this report focuses on the Autologous Cell Therapy Products market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in United States.



By Company


Novartis
Gilead Sciences
Bristol-Myers Squibb
Johnson & Johnson
Autolus Therapeutics
FOSUNKite
JW Therapeutics
CARsgen Therapeutics
Sorrento Therapeutics
Mustang Bio
Cellectis
Allogene Therapeutics
Celyad Oncology
Bluebird Bio
Lonza
Segment by Type
Autologous Stem Cell Transplants
Autologous T Cell Therapies
Platelet-Rich Plasma (PRP) Therapy
Others

Segment by Application


Cancer
Hemophilia
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Autologous Cell Therapy Products definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Autologous Cell Therapy Products companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Autologous Cell Therapy Products in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Autologous Cell Therapy Products sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion

Table of Content

1 Study Coverage
1.1 Autologous Cell Therapy Products Product Introduction
1.2 Global Autologous Cell Therapy Products Outlook 2018 VS 2022 VS 2029
1.2.1 Global Autologous Cell Therapy Products Sales in US$ Million for the Year 2018-2029
1.2.2 Global Autologous Cell Therapy Products Sales in Volume for the Year 2018-2029
1.3 United States Autologous Cell Therapy Products Outlook 2018 VS 2022 VS 2029
1.3.1 United States Autologous Cell Therapy Products Sales in US$ Million for the Year 2018-2029
1.3.2 United States Autologous Cell Therapy Products Sales in Volume for the Year 2018-2029
1.4 Autologous Cell Therapy Products Market Size, United States VS Global, 2018 VS 2022 VS 2029
1.4.1 The Market Share of United States Autologous Cell Therapy Products in Global, 2018 VS 2022 VS 2029
1.4.2 The Growth Rate of Autologous Cell Therapy Products Market Size, United States VS Global, 2018 VS 2022 VS 2029
1.5 Autologous Cell Therapy Products Market Dynamics
1.5.1 Autologous Cell Therapy Products Industry Trends
1.5.2 Autologous Cell Therapy Products Market Drivers
1.5.3 Autologous Cell Therapy Products Market Challenges
1.5.4 Autologous Cell Therapy Products Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Autologous Cell Therapy Products by Type
2.1 Autologous Cell Therapy Products Market Segment by Type
2.1.1 Autologous Stem Cell Transplants
2.1.2 Autologous T Cell Therapies
2.1.3 Platelet-Rich Plasma (PRP) Therapy
2.1.4 Others
2.2 Global Autologous Cell Therapy Products Market Size by Type
2.2.1 Global Autologous Cell Therapy Products Sales in Value, by Type (2018, 2022 & 2029)
2.2.2 Global Autologous Cell Therapy Products Sales in Volume, by Type (2018, 2022 & 2029)
2.2.3 Global Autologous Cell Therapy Products Average Selling Price (ASP) by Type (2018, 2022 & 2029)
2.3 United States Autologous Cell Therapy Products Market Size by Type
2.3.1 United States Autologous Cell Therapy Products Sales in Value, by Type (2018, 2022 & 2029)
2.3.2 United States Autologous Cell Therapy Products Sales in Volume, by Type (2018, 2022 & 2029)
2.3.3 United States Autologous Cell Therapy Products Average Selling Price (ASP) by Type (2018, 2022 & 2029)
3 Autologous Cell Therapy Products by Application
3.1 Autologous Cell Therapy Products Market Segment by Application
3.1.1 Cancer
3.1.2 Hemophilia
3.1.3 Others
3.2 Global Autologous Cell Therapy Products Market Size by Application
3.2.1 Global Autologous Cell Therapy Products Sales in Value, by Application (2018, 2022 & 2029)
3.2.2 Global Autologous Cell Therapy Products Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 Global Autologous Cell Therapy Products Average Selling Price (ASP) by Application (2018, 2022 & 2029)
3.3 United States Autologous Cell Therapy Products Market Size by Application
3.3.1 United States Autologous Cell Therapy Products Sales in Value, by Application (2018, 2022 & 2029)
3.3.2 United States Autologous Cell Therapy Products Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 United States Autologous Cell Therapy Products Average Selling Price (ASP) by Application (2018, 2022 & 2029)
4 Global Autologous Cell Therapy Products Competitor Landscape by Company
4.1 Global Autologous Cell Therapy Products Market Size by Company
4.1.1 Global Key Manufacturers of Autologous Cell Therapy Products, Ranked by Revenue (2022)
4.1.2 Global Autologous Cell Therapy Products Revenue by Manufacturer (2018-2024)
4.1.3 Global Autologous Cell Therapy Products Sales by Manufacturer (2018-2024)
4.1.4 Global Autologous Cell Therapy Products Price by Manufacturer (2018-2024)
4.2 Global Autologous Cell Therapy Products Concentration Ratio (CR)
4.2.1 Autologous Cell Therapy Products Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Autologous Cell Therapy Products in 2022
4.2.3 Global Autologous Cell Therapy Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Autologous Cell Therapy Products, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Autologous Cell Therapy Products, Product Offered and Application
4.5 Global Key Manufacturers of Autologous Cell Therapy Products, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 United States Autologous Cell Therapy Products Market Size by Company
4.7.1 Key Players of Autologous Cell Therapy Products in United States, Ranked by Revenue (2022)
4.7.2 United States Autologous Cell Therapy Products Revenue by Players (2018-2024)
4.7.3 United States Autologous Cell Therapy Products Sales by Players (2018-2024)
5 Global Autologous Cell Therapy Products Market Size by Region
5.1 Global Autologous Cell Therapy Products Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Autologous Cell Therapy Products Market Size in Volume by Region (2018-2029)
5.2.1 Global Autologous Cell Therapy Products Sales in Volume by Region: 2018-2024
5.2.2 Global Autologous Cell Therapy Products Sales in Volume Forecast by Region (2024-2029)
5.3 Global Autologous Cell Therapy Products Market Size in Value by Region (2018-2029)
5.3.1 Global Autologous Cell Therapy Products Sales in Value by Region: 2018-2024
5.3.2 Global Autologous Cell Therapy Products Sales in Value by Region: 2024-2029
6 Americas
6.1 Americas Autologous Cell Therapy Products Market Size YoY Growth 2018-2029
6.2 Americas Autologous Cell Therapy Products Sales in Volume, by Type (2018, 2022 & 2029)
6.3 Americas Autologous Cell Therapy Products Sales in Volume, by Application (2018, 2022 & 2029)
6.4 Americas Autologous Cell Therapy Products Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 Americas Autologous Cell Therapy Products Sales in Value by Country (2018, 2022 & 2029)
6.4.2 Americas Autologous Cell Therapy Products Sales in Volume by Country (2018, 2022 & 2029)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Autologous Cell Therapy Products Market Size YoY Growth 2018-2029
7.2 EMEA Autologous Cell Therapy Products Sales in Volume, by Type (2018, 2022 & 2029)
7.3 EMEA Autologous Cell Therapy Products Sales in Volume, by Application (2018, 2022 & 2029)
7.4 EMEA Autologous Cell Therapy Products Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 EMEA Autologous Cell Therapy Products Sales in Value by Country (2018, 2022 & 2029)
7.4.2 EMEA Autologous Cell Therapy Products Sales in Volume by Country (2018, 2022 & 2029)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Autologous Cell Therapy Products Market Size YoY Growth 2018-2029
8.2 China Autologous Cell Therapy Products Sales in Volume, by Type (2018, 2022 & 2029)
8.3 China Autologous Cell Therapy Products Sales in Volume, by Application (2018, 2022 & 2029)
9 APAC
9.1 APAC Autologous Cell Therapy Products Market Size YoY Growth 2018-2029
9.2 APAC Autologous Cell Therapy Products Sales in Volume, by Type (2018, 2022 & 2029)
9.3 APAC Autologous Cell Therapy Products Sales in Volume, by Application (2018, 2022 & 2029)
9.4 APAC Autologous Cell Therapy Products Market Facts & Figures by Region (2018, 2022 & 2029)
9.4.1 APAC Autologous Cell Therapy Products Sales in Value by Region (2018, 2022 & 2029)
9.4.2 APAC Autologous Cell Therapy Products Sales in Volume by Region (2018, 2022 & 2029)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Novartis
10.1.1 Novartis Company Information
10.1.2 Novartis Description and Business Overview
10.1.3 Novartis Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Novartis Autologous Cell Therapy Products Products Offered
10.1.5 Novartis Recent Development
10.2 Gilead Sciences
10.2.1 Gilead Sciences Company Information
10.2.2 Gilead Sciences Description and Business Overview
10.2.3 Gilead Sciences Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Gilead Sciences Autologous Cell Therapy Products Products Offered
10.2.5 Gilead Sciences Recent Development
10.3 Bristol-Myers Squibb
10.3.1 Bristol-Myers Squibb Company Information
10.3.2 Bristol-Myers Squibb Description and Business Overview
10.3.3 Bristol-Myers Squibb Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Bristol-Myers Squibb Autologous Cell Therapy Products Products Offered
10.3.5 Bristol-Myers Squibb Recent Development
10.4 Johnson & Johnson
10.4.1 Johnson & Johnson Company Information
10.4.2 Johnson & Johnson Description and Business Overview
10.4.3 Johnson & Johnson Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Johnson & Johnson Autologous Cell Therapy Products Products Offered
10.4.5 Johnson & Johnson Recent Development
10.5 Autolus Therapeutics
10.5.1 Autolus Therapeutics Company Information
10.5.2 Autolus Therapeutics Description and Business Overview
10.5.3 Autolus Therapeutics Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Autolus Therapeutics Autologous Cell Therapy Products Products Offered
10.5.5 Autolus Therapeutics Recent Development
10.6 FOSUNKite
10.6.1 FOSUNKite Company Information
10.6.2 FOSUNKite Description and Business Overview
10.6.3 FOSUNKite Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
10.6.4 FOSUNKite Autologous Cell Therapy Products Products Offered
10.6.5 FOSUNKite Recent Development
10.7 JW Therapeutics
10.7.1 JW Therapeutics Company Information
10.7.2 JW Therapeutics Description and Business Overview
10.7.3 JW Therapeutics Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
10.7.4 JW Therapeutics Autologous Cell Therapy Products Products Offered
10.7.5 JW Therapeutics Recent Development
10.8 CARsgen Therapeutics
10.8.1 CARsgen Therapeutics Company Information
10.8.2 CARsgen Therapeutics Description and Business Overview
10.8.3 CARsgen Therapeutics Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
10.8.4 CARsgen Therapeutics Autologous Cell Therapy Products Products Offered
10.8.5 CARsgen Therapeutics Recent Development
10.9 Sorrento Therapeutics
10.9.1 Sorrento Therapeutics Company Information
10.9.2 Sorrento Therapeutics Description and Business Overview
10.9.3 Sorrento Therapeutics Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Sorrento Therapeutics Autologous Cell Therapy Products Products Offered
10.9.5 Sorrento Therapeutics Recent Development
10.10 Mustang Bio
10.10.1 Mustang Bio Company Information
10.10.2 Mustang Bio Description and Business Overview
10.10.3 Mustang Bio Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Mustang Bio Autologous Cell Therapy Products Products Offered
10.10.5 Mustang Bio Recent Development
10.11 Cellectis
10.11.1 Cellectis Company Information
10.11.2 Cellectis Description and Business Overview
10.11.3 Cellectis Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Cellectis Autologous Cell Therapy Products Products Offered
10.11.5 Cellectis Recent Development
10.12 Allogene Therapeutics
10.12.1 Allogene Therapeutics Company Information
10.12.2 Allogene Therapeutics Description and Business Overview
10.12.3 Allogene Therapeutics Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Allogene Therapeutics Autologous Cell Therapy Products Products Offered
10.12.5 Allogene Therapeutics Recent Development
10.13 Celyad Oncology
10.13.1 Celyad Oncology Company Information
10.13.2 Celyad Oncology Description and Business Overview
10.13.3 Celyad Oncology Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Celyad Oncology Autologous Cell Therapy Products Products Offered
10.13.5 Celyad Oncology Recent Development
10.14 Bluebird Bio
10.14.1 Bluebird Bio Company Information
10.14.2 Bluebird Bio Description and Business Overview
10.14.3 Bluebird Bio Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Bluebird Bio Autologous Cell Therapy Products Products Offered
10.14.5 Bluebird Bio Recent Development
10.15 Lonza
10.15.1 Lonza Company Information
10.15.2 Lonza Description and Business Overview
10.15.3 Lonza Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Lonza Autologous Cell Therapy Products Products Offered
10.15.5 Lonza Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Autologous Cell Therapy Products Industry Chain Analysis
11.2 Autologous Cell Therapy Products Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Autologous Cell Therapy Products Production Mode & Process
11.4 Autologous Cell Therapy Products Sales and Marketing
11.4.1 Autologous Cell Therapy Products Sales Channels
11.4.2 Autologous Cell Therapy Products Distributors
11.5 Autologous Cell Therapy Products Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Figure

List of Tables
Table 1. Autologous Cell Therapy Products CAGR in Value, United States VS Global, 2018 VS 2022 VS 2029
Table 2. Autologous Cell Therapy Products Market Trends
Table 3. Autologous Cell Therapy Products Market Drivers
Table 4. Autologous Cell Therapy Products Market Challenges
Table 5. Autologous Cell Therapy Products Market Restraints
Table 6. Global Autologous Cell Therapy Products Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. United States Autologous Cell Therapy Products Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Autologous Cell Therapy Products Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. United States Autologous Cell Therapy Products Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 10. Global Key Manufacturers of Autologous Cell Therapy Products, Ranked by Revenue (2022) & (US$ Million)
Table 11. Global Autologous Cell Therapy Products Revenue by Manufacturer, (US$ Million), 2018-2024
Table 12. Global Autologous Cell Therapy Products Revenue Share by Manufacturer, 2018-2024
Table 13. Global Autologous Cell Therapy Products Sales by Manufacturer, (K Units), 2018-2024
Table 14. Global Autologous Cell Therapy Products Sales Share by Manufacturer, 2018-2024
Table 15. Global Autologous Cell Therapy Products Price by Manufacturer (2018-2024) & (US$/Unit)
Table 16. Global Autologous Cell Therapy Products Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Autologous Cell Therapy Products by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autologous Cell Therapy Products as of 2022)
Table 18. Global Key Manufacturers of Autologous Cell Therapy Products, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Autologous Cell Therapy Products, Product Offered and Application
Table 20. Global Key Manufacturers of Autologous Cell Therapy Products, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Autologous Cell Therapy Products in United States, Ranked by Revenue (2022) & (US$ million)
Table 23. United States Autologous Cell Therapy Products Revenue by Players, (US$ Million), (2018-2024)
Table 24. United States Autologous Cell Therapy Products Revenue Share by Players, (2018-2024)
Table 25. United States Autologous Cell Therapy Products Sales by Players, (K Units), (2018-2024)
Table 26. United States Autologous Cell Therapy Products Sales Share by Players, (2018-2024)
Table 27. Global Autologous Cell Therapy Products Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 28. Global Autologous Cell Therapy Products Sales in Volume by Region (2018-2024) & (K Units)
Table 29. Global Autologous Cell Therapy Products Sales in Volume Forecast by Region (2024-2029) & (K Units)
Table 30. Global Autologous Cell Therapy Products Sales in Value by Region (2018-2024) & (US$ Million)
Table 31. Global Autologous Cell Therapy Products Sales in Value Forecast by Region (2024-2029) & (US$ Million)
Table 32. Americas Autologous Cell Therapy Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. Americas Autologous Cell Therapy Products Sales in Value by Country (2018-2024) & (US$ Million)
Table 34. Americas Autologous Cell Therapy Products Sales in Value by Country (2024-2029) & (US$ Million)
Table 35. Americas Autologous Cell Therapy Products Sales in Volume by Country (2018-2024) & (K Units)
Table 36. Americas Autologous Cell Therapy Products Sales in Volume by Country (2024-2029) & (K Units)
Table 37. EMEA Autologous Cell Therapy Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. EMEA Autologous Cell Therapy Products Sales in Value by Country (2018-2024) & (US$ Million)
Table 39. EMEA Autologous Cell Therapy Products Sales in Value by Country (2024-2029) & (US$ Million)
Table 40. EMEA Autologous Cell Therapy Products Sales in Volume by Country (2018-2024) & (K Units)
Table 41. EMEA Autologous Cell Therapy Products Sales in Volume by Country (2024-2029) & (K Units)
Table 42. APAC Autologous Cell Therapy Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. APAC Autologous Cell Therapy Products Sales in Value by Country (2018-2024) & (US$ Million)
Table 44. APAC Autologous Cell Therapy Products Sales in Value by Country (2024-2029) & (US$ Million)
Table 45. APAC Autologous Cell Therapy Products Sales in Volume by Country (2018-2024) & (K Units)
Table 46. APAC Autologous Cell Therapy Products Sales in Volume by Country (2024-2029) & (K Units)
Table 47. Novartis Company Information
Table 48. Novartis Description and Business Overview
Table 49. Novartis Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 50. Novartis Autologous Cell Therapy Products Product
Table 51. Novartis Recent Development
Table 52. Gilead Sciences Company Information
Table 53. Gilead Sciences Description and Business Overview
Table 54. Gilead Sciences Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 55. Gilead Sciences Autologous Cell Therapy Products Product
Table 56. Gilead Sciences Recent Development
Table 57. Bristol-Myers Squibb Company Information
Table 58. Bristol-Myers Squibb Description and Business Overview
Table 59. Bristol-Myers Squibb Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 60. Bristol-Myers Squibb Autologous Cell Therapy Products Product
Table 61. Bristol-Myers Squibb Recent Development
Table 62. Johnson & Johnson Company Information
Table 63. Johnson & Johnson Description and Business Overview
Table 64. Johnson & Johnson Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 65. Johnson & Johnson Autologous Cell Therapy Products Product
Table 66. Johnson & Johnson Recent Development
Table 67. Autolus Therapeutics Company Information
Table 68. Autolus Therapeutics Description and Business Overview
Table 69. Autolus Therapeutics Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 70. Autolus Therapeutics Autologous Cell Therapy Products Product
Table 71. Autolus Therapeutics Recent Development
Table 72. FOSUNKite Company Information
Table 73. FOSUNKite Description and Business Overview
Table 74. FOSUNKite Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 75. FOSUNKite Autologous Cell Therapy Products Product
Table 76. FOSUNKite Recent Development
Table 77. JW Therapeutics Company Information
Table 78. JW Therapeutics Description and Business Overview
Table 79. JW Therapeutics Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 80. JW Therapeutics Autologous Cell Therapy Products Product
Table 81. JW Therapeutics Recent Development
Table 82. CARsgen Therapeutics Company Information
Table 83. CARsgen Therapeutics Description and Business Overview
Table 84. CARsgen Therapeutics Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 85. CARsgen Therapeutics Autologous Cell Therapy Products Product
Table 86. CARsgen Therapeutics Recent Development
Table 87. Sorrento Therapeutics Company Information
Table 88. Sorrento Therapeutics Description and Business Overview
Table 89. Sorrento Therapeutics Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 90. Sorrento Therapeutics Autologous Cell Therapy Products Product
Table 91. Sorrento Therapeutics Recent Development
Table 92. Mustang Bio Company Information
Table 93. Mustang Bio Description and Business Overview
Table 94. Mustang Bio Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 95. Mustang Bio Autologous Cell Therapy Products Product
Table 96. Mustang Bio Recent Development
Table 97. Cellectis Company Information
Table 98. Cellectis Description and Business Overview
Table 99. Cellectis Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 100. Cellectis Autologous Cell Therapy Products Product
Table 101. Cellectis Recent Development
Table 102. Allogene Therapeutics Company Information
Table 103. Allogene Therapeutics Description and Business Overview
Table 104. Allogene Therapeutics Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 105. Allogene Therapeutics Autologous Cell Therapy Products Product
Table 106. Allogene Therapeutics Recent Development
Table 107. Celyad Oncology Company Information
Table 108. Celyad Oncology Description and Business Overview
Table 109. Celyad Oncology Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Celyad Oncology Autologous Cell Therapy Products Product
Table 111. Celyad Oncology Recent Development
Table 112. Bluebird Bio Company Information
Table 113. Bluebird Bio Description and Business Overview
Table 114. Bluebird Bio Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Bluebird Bio Autologous Cell Therapy Products Product
Table 116. Bluebird Bio Recent Development
Table 117. Lonza Company Information
Table 118. Lonza Description and Business Overview
Table 119. Lonza Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Lonza Autologous Cell Therapy Products Product
Table 121. Lonza Recent Development
Table 122. Key Raw Materials Lists
Table 123. Raw Materials Key Suppliers Lists
Table 124. Autologous Cell Therapy Products Customers List
Table 125. Autologous Cell Therapy Products Distributors List
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Autologous Cell Therapy Products Product Picture
Figure 2. Global Autologous Cell Therapy Products Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Autologous Cell Therapy Products Market Size 2018-2029 (US$ Million)
Figure 4. Global Autologous Cell Therapy Products Sales 2018-2029 (K Units)
Figure 5. United States Autologous Cell Therapy Products Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 6. United States Autologous Cell Therapy Products Market Size 2018-2029 (US$ Million)
Figure 7. United States Autologous Cell Therapy Products Sales 2018-2029 (K Units)
Figure 8. United States Autologous Cell Therapy Products Market Share in Global, in Value (US$ Million) 2018-2029
Figure 9. United States Autologous Cell Therapy Products Market Share in Global, in Volume (K Units) 2018-2029
Figure 10. Autologous Cell Therapy Products Report Years Considered
Figure 11. Product Picture of Autologous Stem Cell Transplants
Figure 12. Product Picture of Autologous T Cell Therapies
Figure 13. Product Picture of Platelet-Rich Plasma (PRP) Therapy
Figure 14. Product Picture of Others
Figure 15. Global Autologous Cell Therapy Products Market Share by Type in 2022 & 2029
Figure 16. Global Autologous Cell Therapy Products Sales in Value by Type (2018-2029) & (US$ Million)
Figure 17. Global Autologous Cell Therapy Products Sales Market Share in Value by Type (2018-2029)
Figure 18. Global Autologous Cell Therapy Products Sales by Type (2018-2029) & (K Units)
Figure 19. Global Autologous Cell Therapy Products Sales Market Share in Volume by Type (2018-2029)
Figure 20. Global Autologous Cell Therapy Products Price by Type (2018-2029) & (US$/Unit)
Figure 21. United States Autologous Cell Therapy Products Market Share by Type in 2022 & 2029
Figure 22. United States Autologous Cell Therapy Products Sales in Value by Type (2018-2029) & (US$ Million)
Figure 23. United States Autologous Cell Therapy Products Sales Market Share in Value by Type (2018-2029)
Figure 24. United States Autologous Cell Therapy Products Sales by Type (2018-2029) & (K Units)
Figure 25. United States Autologous Cell Therapy Products Sales Market Share in Volume by Type (2018-2029)
Figure 26. United States Autologous Cell Therapy Products Price by Type (2018-2029) & (US$/Unit)
Figure 27. Product Picture of Cancer
Figure 28. Product Picture of Hemophilia
Figure 29. Product Picture of Others
Figure 30. Global Autologous Cell Therapy Products Market Share by Application in 2022 & 2029
Figure 31. Global Autologous Cell Therapy Products Sales in Value by Application (2018-2029) & (US$ Million)
Figure 32. Global Autologous Cell Therapy Products Sales Market Share in Value by Application (2018-2029)
Figure 33. Global Autologous Cell Therapy Products Sales by Application (2018-2029) & (K Units)
Figure 34. Global Autologous Cell Therapy Products Sales Market Share in Volume by Application (2018-2029)
Figure 35. Global Autologous Cell Therapy Products Price by Application (2018-2029) & (US$/Unit)
Figure 36. United States Autologous Cell Therapy Products Market Share by Application in 2022 & 2029
Figure 37. United States Autologous Cell Therapy Products Sales in Value by Application (2018-2029) & (US$ Million)
Figure 38. United States Autologous Cell Therapy Products Sales Market Share in Value by Application (2018-2029)
Figure 39. United States Autologous Cell Therapy Products Sales by Application (2018-2029) & (K Units)
Figure 40. United States Autologous Cell Therapy Products Sales Market Share in Volume by Application (2018-2029)
Figure 41. United States Autologous Cell Therapy Products Price by Application (2018-2029) & (US$/Unit)
Figure 42. Americas Autologous Cell Therapy Products Sales in Volume Growth Rate 2018-2029 (K Units)
Figure 43. Americas Autologous Cell Therapy Products Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 44. Americas Autologous Cell Therapy Products Sales by Type (2018-2029) & (K Units)
Figure 45. Americas Autologous Cell Therapy Products Sales Market Share in Volume by Type (2018-2029)
Figure 46. Americas Autologous Cell Therapy Products Sales by Application (2018-2029) & (K Units)
Figure 47. Americas Autologous Cell Therapy Products Sales Market Share in Volume by Application (2018-2029)
Figure 48. United States Autologous Cell Therapy Products Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 49. Canada Autologous Cell Therapy Products Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 50. Mexico Autologous Cell Therapy Products Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 51. Brazil Autologous Cell Therapy Products Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 52. EMEA Autologous Cell Therapy Products Sales in Volume Growth Rate 2018-2029 (K Units)
Figure 53. EMEA Autologous Cell Therapy Products Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 54. EMEA Autologous Cell Therapy Products Sales by Type (2018-2029) & (K Units)
Figure 55. EMEA Autologous Cell Therapy Products Sales Market Share in Volume by Type (2018-2029)
Figure 56. EMEA Autologous Cell Therapy Products Sales by Application (2018-2029) & (K Units)
Figure 57. EMEA Autologous Cell Therapy Products Sales Market Share in Volume by Application (2018-2029)
Figure 58. Europe Autologous Cell Therapy Products Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 59. Middle East Autologous Cell Therapy Products Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 60. Africa Autologous Cell Therapy Products Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 61. China Autologous Cell Therapy Products Sales in Volume Growth Rate 2018-2029 (K Units)
Figure 62. China Autologous Cell Therapy Products Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 63. China Autologous Cell Therapy Products Sales by Type (2018-2029) & (K Units)
Figure 64. China Autologous Cell Therapy Products Sales Market Share in Volume by Type (2018-2029)
Figure 65. China Autologous Cell Therapy Products Sales by Application (2018-2029) & (K Units)
Figure 66. China Autologous Cell Therapy Products Sales Market Share in Volume by Application (2018-2029)
Figure 67. APAC Autologous Cell Therapy Products Sales in Volume Growth Rate 2018-2029 (K Units)
Figure 68. APAC Autologous Cell Therapy Products Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 69. APAC Autologous Cell Therapy Products Sales by Type (2018-2029) & (K Units)
Figure 70. APAC Autologous Cell Therapy Products Sales Market Share in Volume by Type (2018-2029)
Figure 71. APAC Autologous Cell Therapy Products Sales by Application (2018-2029) & (K Units)
Figure 72. APAC Autologous Cell Therapy Products Sales Market Share in Volume by Application (2018-2029)
Figure 73. Japan Autologous Cell Therapy Products Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 74. South Korea Autologous Cell Therapy Products Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 75. China Taiwan Autologous Cell Therapy Products Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 76. Southeast Asia Autologous Cell Therapy Products Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 77. India Autologous Cell Therapy Products Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 78. Autologous Cell Therapy Products Value Chain
Figure 79. Autologous Cell Therapy Products Production Process
Figure 80. Channels of Distribution
Figure 81. Distributors Profiles
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries